
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?
1. Novo Nordisk (NYSE:NVO) has slumped over 31% this week after the company lowered its 2025 sales outlook. The company cited reduced growth expectations for Wegovy and Ozempic in the US and weaker Wegovy penetration.